AI News
05 Mar 2026
Read 8 min
How to Prepare for the federal ban on Anthropic Claude
federal ban on Anthropic Claude forces agencies to pivot to approved AI tools to protect drug reviews
Federal agencies are moving fast to restrict access to Anthropic’s tool. To stay compliant and avoid downtime, teams should pause new usage, inventory where Claude is embedded, and migrate core workflows to approved systems like ChatGPT Enterprise and Google Gemini. The federal ban on Anthropic Claude will affect reviews, collaboration, and data controls—prepare now.
The U.S. Department of Health and Human Services confirmed that staff must stop using Claude. Other options, including OpenAI’s ChatGPT Enterprise and Google Gemini, still remain available for authorized mission work. This shift could slow some FDA review tasks, as the agency’s Elsa assistant started on Claude. Internal emails told employees to discontinue the platform and move to approved AI tools. The move follows a directive from President Donald Trump to phase out Anthropic across the federal government.
Freeze new projects that rely on Claude and block logins where required.
List every workflow, prompt, and integration that uses Claude (apps, add-ons, scripts).
Identify approved replacements (ChatGPT Enterprise, Google Gemini) for each use case.
Assign owners for migration, testing, and sign-off.
Communicate dates, changes, and support channels to all users.
Group tasks by risk: public info, internal drafts, sensitive health or patient data.
Decide which tasks can shift now and which need extra controls or redaction.
Export prompts and system messages from Claude projects.
Rewrite any Claude-specific instructions (tool names, parameters) for the new model.
Load internal style guides and policies into the new platform’s memory or knowledge base.
Create 10–20 gold-standard test cases per workflow.
Compare outputs for accuracy, bias, and regulatory tone.
Tune prompts, temperature, and safety settings until results match requirements.
Run both systems in parallel for high-risk tasks until quality holds for two weeks.
Decommission Claude access and archive logs per policy.
Use enterprise tenants, not consumer accounts, for ChatGPT or Gemini.
Confirm data handling: retention, training opt-out, encryption, and regional storage.
Limit who can create connectors, upload datasets, or call external tools.
Enable audit logs and route them to your SIEM.
Redact PII/PHI by default; allow exceptions only with approvals and DLP in place.
Document model versions used for decisions and keep change records.
Map any Elsa or review playbooks that referenced Claude to the new model.
Recreate templates for summaries, labeling, and meeting notes.
Pre-build safe toolchains for literature scans, comment triage, and evidence tables.
Schedule joint dry runs with regulatory, clinical, and IT before go-live.
Add clauses that allow switching vendors if a tool is later banned.
Negotiate data portability for prompts, embeddings, and logs.
Define service levels, model update notice, and explainability support.
Require compliance attestations and third-party security reviews.
Create short guides: how to log in, approved uses, and what not to do.
Offer 30-minute role-based trainings with live demos and sample prompts.
Set up office hours and a feedback form for broken workflows.
Appoint “AI champions” in each team to coach peers.
Time saved per task vs. baseline.
Error rates and rework on regulated documents.
User satisfaction and adoption by role.
Security incidents and policy exceptions.
Queue and cycle time for reviews or approvals.
Preparing for the federal ban on Anthropic Claude: What to do now
What changes for HHS, FDA, and health partners
The FDA has used AI to speed reviews, including the Elsa tool, which began on Claude. Teams should expect short-term friction as prompts, connectors, and review playbooks move to new models. If you work with regulated data, reinforce privacy, access, and audit settings before you switch users back on.A fast migration plan to ChatGPT Enterprise or Gemini
1) Audit use cases and risk
2) Port prompts, guardrails, and knowledge
3) Validate quality and performance
4) Cutover with checkpoints
Security, privacy, and compliance checkpoints
Continuity for FDA-facing and clinical teams
Procurement and contracts under shifting policy
Training and change management that sticks
Measure outcomes after the switch
The road ahead
Policy shifts will continue. By documenting dependencies, hardening data controls, and proving quality on new models, your team can reduce risk and keep work moving. Treat the federal ban on Anthropic Claude as a trigger to standardize AI governance, improve portability, and build resilience across tools—starting today.For more news: Click Here
FAQ
Q: What action did the Department of Health and Human Services take about Claude?
A: HHS told employees they can no longer log in to or access Claude through the HHS enterprise environment and instructed staff to discontinue use of the platform. The department directed teams to transition work to other approved enterprise AI solutions, reflecting the federal ban on Anthropic Claude after a presidential order to phase out Anthropic products.
Q: Which AI tools remain available for authorized mission use at HHS?
A: HHS confirmed that OpenAI’s ChatGPT Enterprise and Google Gemini remain available for authorized mission-related use. Organizations are advised to use enterprise tenants and approved accounts to stay compliant under the federal ban on Anthropic Claude.
Q: How might the federal ban on Anthropic Claude affect FDA review work?
A: The loss of Claude could hinder FDA efforts to hasten drug reviews because the Elsa assistant used by the agency was originally developed based on Claude. Teams should expect short-term friction as prompts, connectors, and review playbooks move to other models.
Q: What immediate steps should teams take to prepare for the federal ban on Anthropic Claude?
A: Teams should pause new projects that rely on Claude, inventory every workflow, prompt, and integration that uses the tool, and identify approved replacements like ChatGPT Enterprise or Google Gemini. They should assign owners for migration, testing, and sign-off, and communicate dates and support channels to users to avoid downtime.
Q: How should prompts and knowledge be migrated from Claude to another model?
A: Export prompts and system messages from Claude projects, rewrite any Claude-specific instructions for the new model, and load internal style guides and policies into the replacement platform’s knowledge base. Then validate quality with gold-standard test cases and tune prompts, temperature, and safety settings until results meet requirements.
Q: What security and compliance checkpoints are recommended before switching users back on?
A: Use enterprise tenants rather than consumer accounts and confirm data handling details such as retention, training opt-out, encryption, and regional storage before re-enabling access. Limit who can create connectors or upload datasets, enable audit logs routed to your SIEM, and redact PII/PHI by default to meet compliance under the federal ban on Anthropic Claude.
Q: What procurement and contract changes should agencies make in response to the federal ban on Anthropic Claude?
A: Add contract clauses that allow switching vendors if a tool is later banned, negotiate data portability for prompts, embeddings, and logs, and define service levels, model update notice, and explainability support. Require compliance attestations and third-party security reviews to reduce vendor risk during transitions.
Q: Which metrics should teams track after switching away from Claude?
A: Track time saved per task versus baseline, error rates and rework on regulated documents, user satisfaction and adoption by role, and security incidents or policy exceptions. Also measure queue and cycle time for reviews or approvals to prove quality on replacement models and demonstrate resilience after the federal ban on Anthropic Claude.
Contents
